Volibo R 0.2/0.5MG Tab

Composition

Metformin (500mg) + Voglibose (0.2mg)

Uses of Volibo R 0.2/0.5MG Tab

Type 2 diabetes mellitus: to improve post-meal and overall blood glucose control when diet and exercise alone are insufficient; used when combination therapy is required.

• •Reduces post-meal blood sugar spikes
• •Improves overall glycaemic control in type 2 diabetes
• •Short-acting meal-time glucose control
• •Can help when single therapy is inadequate

How it works

Voglibose is an alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestine, reducing post-meal glucose spikes. Repaglinide is a short-acting insulin secretagogue (meglitinide) that stimulates pancreatic insulin release, mainly around meals, thereby lowering postprandial blood glucose.

Directions for use

Oral tablet. Take exactly as prescribed. Typically taken before meals (repaglinide is usually taken 15–30 minutes before each main meal; skip the dose if you skip a meal). Voglibose is usually taken just before/with the first bite of meal. Follow your doctor’s instructions for this fixed-dose combination; monitor blood glucose regularly.

Side effects

Common side effects of Volibo R 0.2/0.5MG Tab may include:

• •Hypoglycaemia
• •abdominal pain
• •flatulence
• •diarrhoea
• •